Top

Journal of Neuro-Oncology

Published in:

01-04-2016 | Letter to the Editor

Response of symptomatic brain metastases from HER-2 overexpressing breast cancer with T-DM1

Authors: C. L. Gorter de Vries, S. C. Linn, D. Brandsma

Published in: Journal of Neuro-Oncology | Issue 2/2016

Excerpt

To the Editor, …

Ross J, Slodkowsaka E, Symmans W et al (2009) The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine. Oncologist 14:320–369CrossRefPubMed

Verma S, Miles D, Gianni L et al for the EMILIA Study Group (2012) Trastuzumab emtansine for HER2-positive advanced breast cancer. N Engl J Med 367:1783–1791

Metro G, Foglietta J, Russillo M et al (2011) Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine. Ann Oncol 22(3):625–630CrossRefPubMed

Bartsch R, Berghoff A, Preusser M (2014) Breast cancer brain metastases responding to primary systemic therapy with T-DM1. J Neurooncol 116:205–206CrossRefPubMed

Torres S, Maralani P, Verma S (2014) Activity of T-DM1 in HER-2 positive central nervous system breast cancer metastases. BMJ Case Rep. doi:10.1136/bcr-2014-205680

Gebhart G, Lamberts LE, Wimana Z et al (2015) Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR Trial. Ann Oncol. doi:10.1093/annonc/mdv577

Title: Response of symptomatic brain metastases from HER-2 overexpressing breast cancer with T-DM1
Authors: C. L. Gorter de Vries
S. C. Linn
D. Brandsma
Publication date: 01-04-2016
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 2/2016
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-015-2045-1

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Response of symptomatic brain metastases from HER-2 overexpressing breast cancer with T-DM1

Excerpt

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2016

Cognitive effects of donepezil therapy in patients with brain tumors: a pilot study

Advances in HSP27 and HSP90-targeting strategies for glioblastoma

Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas

Quick, non-invasive and quantitative assessment of small fiber neuropathy in patients receiving chemotherapy

Spinal meningeal melanocytomas: clinical manifestations, radiological and pathological characteristics, and surgical outcomes

Combination treatment with fasudil and clioquinol produces synergistic anti-tumor effects in U87 glioblastoma cells by activating apoptosis and autophagy